In 2022, Matthew Doctor earned $897.86K in total compensation at Regis Corporation, including $600.00K salary and $259.00K bonus. Most recently acquired 46,992 shares in Nov 2021. Currently holds stock worth $565.98K. 3+ years at the helm of Regis Corporation.
Compensation History
Annual executive compensation data for Matthew Doctor, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$897.86K
Salary
$600.00K
Bonus
$259.00K
Other
$38.86K
Salary
$600.00KBoard Justification
The executive compensation programs are designed to reward executives for achieving financial and business goals while aligning their interests with those of shareholders.
Bonus
$259.00KBoard Justification
Discretionary bonus payments made for One-Time Cash Bonuses and ReFi Recognition Bonuses due to the Company’s over performance on the Adjusted EBITDA metric.
Other Compensation
$38.86KBoard Justification
Includes company match and profit-sharing contributions to retirement savings plans.
Restricted Stock
Board Justification
No stock awards vested in 2022 as Mr. Doctor did not receive an annual long-term equity grant in fiscal 2023 due to prior large equity awards.
Performance Metrics
Company performance metrics tied to target Adjusted EBITDA and key initiatives related to the Company’s ongoing performance.
Matthew Doctor
CEO of Regis Corporation
Education
Not specified
Field of Expertise
Business & Management
Sector of Economy
Consumer Cyclical
Born
January 1, 1987 - 38 years ago
CEO of Regis Corporation for
3 years 7 months (May 2022 - Present)
Previous Experience
Executive Vice President and Chief Strategy Officer, Chief Financial Officer of Kava Restaurants LLC, various roles at Restaurant Brands International
Other Regis Corporation CEOs
Holdings
Track Matthew Doctor's stock holdings and portfolio value over time.
Insider Trading
Matthew Doctor's recent stock transactions, purchases, and sales filed with the SEC.
$64.85K
RGS at $1.38/share
Nov 5, 2021
Received
46,344 shares
RGS
Nov 5, 2021
Received
28,382 shares
RGS
Feb 8, 2021
Received
Rivals
Compare Matthew Doctor with competitor CEOs and industry peers.